Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 04:00PM ET
79.69
Dollar change
-1.13
Percentage change
-1.40
%
IndexNDX, S&P 500 P/E23.26 EPS (ttm)3.43 Insider Own7.01% Shs Outstand455.34M Perf Week-3.37%
Market Cap36.38B Forward P/E16.73 EPS next Y4.76 Insider Trans-0.28% Shs Float424.46M Perf Month1.07%
Income1.57B PEG2.02 EPS next Q0.98 Inst Own75.27% Short Float2.99% Perf Quarter-7.60%
Sales19.50B P/S1.87 EPS this Y8.67% Inst Trans- Short Ratio4.56 Perf Half Y8.17%
Book/sh16.23 P/B4.91 EPS next Y11.53% ROA4.85% Short Interest12.71M Perf Year-1.17%
Cash/sh5.61 P/C14.19 EPS next 5Y11.50% ROE22.33% 52W Range62.35 - 94.50 Perf YTD3.07%
Dividend Est.0.12 (0.15%) P/FCF21.87 EPS past 5Y-2.54% ROI9.84% 52W High-15.67% Beta1.37
Dividend TTM0.12 (0.15%) Quick Ratio0.79 Sales past 5Y4.14% Gross Margin40.74% 52W Low27.81% ATR (14)1.57
Dividend Ex-DateJul 19, 2024 Current Ratio1.01 EPS Y/Y TTM-8.71% Oper. Margin13.42% RSI (14)50.85 Volatility1.98% 1.92%
Employees51000 Debt/Eq1.31 Sales Y/Y TTM4.22% Profit Margin8.05% Recom1.84 Target Price92.15
Option/ShortYes / Yes LT Debt/Eq1.15 EPS Q/Q97.00% Payout3.97% Rel Volume0.90 Prev Close80.82
Sales Surprise-3.15% EPS Surprise-0.75% Sales Q/Q-1.21% EarningsJul 31 BMO Avg Volume2.79M Price79.69
SMA200.76% SMA500.94% SMA2001.57% Trades Volume2,517,042 Change-1.40%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Neutral $87
Feb-15-24Initiated HSBC Securities Buy $100
Feb-12-24Upgrade UBS Sell → Neutral $66 → $88
Nov-30-23Initiated Jefferies Hold $80
Nov-27-23Downgrade UBS Neutral → Sell $86 → $66
Sep-19-23Initiated Citigroup Buy $82
Aug-25-23Initiated Argus Buy $80
Aug-16-23Initiated Wells Fargo Overweight $90
Jul-31-23Initiated BofA Securities Neutral $82
Jun-27-23Initiated Morgan Stanley Equal-Weight $76
Today 08:45AM
Jul-21-24 10:00AM
Jul-18-24 03:26AM
Jul-15-24 12:15PM
Jul-13-24 08:45PM
06:54AM Loading…
Jul-12-24 06:54AM
Jul-11-24 02:01PM
Jul-10-24 10:15AM
Jul-08-24 08:00AM
Jul-02-24 11:56AM
Jun-28-24 08:28PM
08:26PM
Jun-26-24 12:32PM
09:52AM
Jun-25-24 12:46PM
11:20AM Loading…
Jun-24-24 11:20AM
10:00AM
Jun-20-24 10:47AM
Jun-17-24 12:12PM
Jun-10-24 04:06PM
Jun-07-24 12:40PM
Jun-04-24 09:00AM
May-30-24 10:00AM
May-28-24 06:45AM
May-26-24 09:58PM
May-22-24 06:39PM
09:00AM
May-21-24 09:00AM
May-15-24 12:08PM
May-14-24 09:00AM
02:25PM Loading…
May-13-24 02:25PM
May-10-24 09:00AM
May-07-24 08:19AM
May-06-24 08:05AM
06:58AM
May-05-24 08:00AM
May-03-24 09:53AM
May-02-24 04:05PM
May-01-24 09:30AM
Apr-30-24 04:41PM
04:29PM
12:56PM
12:37PM
12:21PM
10:54AM
10:32AM
09:30AM
07:30AM
06:20AM
Apr-29-24 09:00AM
Apr-28-24 08:00AM
Apr-25-24 09:13PM
Apr-24-24 11:34AM
09:30AM
Apr-23-24 05:50PM
01:38PM
Apr-22-24 06:00PM
11:10AM
07:07AM
Apr-19-24 09:55AM
Apr-18-24 10:32AM
09:00AM
Apr-17-24 10:48AM
Apr-16-24 08:00AM
Apr-15-24 01:18PM
Apr-13-24 12:16PM
Apr-12-24 08:00AM
Apr-09-24 08:05AM
07:37AM
Apr-08-24 01:31PM
Apr-05-24 03:41PM
Apr-04-24 12:03PM
09:30AM
Apr-03-24 08:00AM
Apr-02-24 04:46PM
07:35AM
07:31AM
Apr-01-24 06:13PM
01:26PM
Mar-28-24 11:30AM
Mar-27-24 08:00AM
Mar-26-24 11:17AM
Mar-25-24 10:20AM
09:00AM
Mar-22-24 11:00AM
10:51AM
12:33AM
Mar-21-24 12:32PM
Mar-19-24 09:30AM
Mar-18-24 06:00PM
Mar-15-24 11:15AM
Mar-14-24 01:30PM
Mar-13-24 04:10PM
09:30AM
Mar-12-24 10:28PM
04:34PM
09:00AM
Mar-11-24 12:33PM
Mar-07-24 11:31AM
09:00AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company's history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kass-Hout TahaChief Technology OfficerMay 28 '24Sale78.703,300259,71067,300May 29 04:05 PM
Makela JanCEO, ImagingMay 15 '24Option Exercise74.3566,9554,978,229130,303May 15 07:15 PM
Makela JanCEO, ImagingMay 15 '24Sale81.5466,9555,459,51163,348May 15 07:15 PM
Makela JanCEO, ImagingMay 13 '24Option Exercise63.5120,2271,284,61783,575May 15 07:15 PM
Makela JanCEO, ImagingMay 13 '24Sale81.5720,2271,649,91663,348May 15 07:15 PM
Jimenez Frank RGC & Corporate SecretaryMay 01 '24Buy76.521,315100,62475,796May 02 06:00 AM
O'Neill Kevin MichaelCEO, PDxJul 31 '23Option Exercise40.4013,275536,31037,300Aug 02 04:05 PM
O'Neill Kevin MichaelCEO, PDxJul 31 '23Sale77.3215,6091,206,94924,025Aug 02 04:05 PM